Elena Halley Chartoff, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Opioid, kappa | 12 | 2019 | 144 | 3.760 |
Why?
|
| Nucleus Accumbens | 16 | 2022 | 366 | 3.280 |
Why?
|
| Oxycodone | 6 | 2023 | 153 | 2.880 |
Why?
|
| Substance Withdrawal Syndrome | 10 | 2020 | 632 | 2.480 |
Why?
|
| Reward | 15 | 2023 | 940 | 2.330 |
Why?
|
| Dopamine | 12 | 2022 | 1591 | 2.140 |
Why?
|
| Behavior, Addictive | 5 | 2020 | 462 | 1.950 |
Why?
|
| Self Stimulation | 8 | 2021 | 55 | 1.950 |
Why?
|
| Narcotics | 4 | 2020 | 343 | 1.420 |
Why?
|
| Morphine Dependence | 4 | 2016 | 31 | 1.410 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 3 | 2019 | 24 | 1.370 |
Why?
|
| Morphine | 4 | 2020 | 657 | 1.330 |
Why?
|
| Diterpenes, Clerodane | 5 | 2015 | 43 | 1.240 |
Why?
|
| Cocaine | 10 | 2015 | 1007 | 1.150 |
Why?
|
| Receptors, Dopamine D1 | 6 | 2022 | 291 | 1.080 |
Why?
|
| Ventral Tegmental Area | 8 | 2018 | 142 | 1.070 |
Why?
|
| Rats, Sprague-Dawley | 28 | 2023 | 8300 | 1.060 |
Why?
|
| Narcotic Antagonists | 6 | 2019 | 562 | 1.050 |
Why?
|
| Analgesics, Opioid | 7 | 2023 | 3677 | 1.020 |
Why?
|
| Rats | 35 | 2023 | 24252 | 0.920 |
Why?
|
| Neurobiology | 2 | 2020 | 121 | 0.770 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 7 | 2011 | 514 | 0.770 |
Why?
|
| Sucrose | 2 | 2020 | 164 | 0.740 |
Why?
|
| Receptors, Opioid | 2 | 2018 | 155 | 0.730 |
Why?
|
| Pyrrolidines | 3 | 2019 | 342 | 0.700 |
Why?
|
| Self Administration | 9 | 2021 | 385 | 0.690 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2019 | 91 | 0.680 |
Why?
|
| Anti-Anxiety Agents | 2 | 2019 | 390 | 0.680 |
Why?
|
| Sex Characteristics | 3 | 2020 | 2585 | 0.650 |
Why?
|
| Motivation | 3 | 2018 | 1971 | 0.650 |
Why?
|
| Opioid-Related Disorders | 5 | 2021 | 2064 | 0.570 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2019 | 366 | 0.550 |
Why?
|
| Receptors, AMPA | 2 | 2016 | 332 | 0.550 |
Why?
|
| Naloxone | 4 | 2009 | 367 | 0.540 |
Why?
|
| Benzazepines | 6 | 2009 | 326 | 0.540 |
Why?
|
| Food | 1 | 2020 | 772 | 0.530 |
Why?
|
| Benzamides | 2 | 2019 | 1379 | 0.530 |
Why?
|
| Conditioning, Operant | 5 | 2020 | 313 | 0.520 |
Why?
|
| Corpus Striatum | 7 | 2017 | 1221 | 0.520 |
Why?
|
| Behavior, Animal | 6 | 2019 | 1881 | 0.500 |
Why?
|
| Dynorphins | 2 | 2018 | 84 | 0.490 |
Why?
|
| Sweetening Agents | 1 | 2017 | 296 | 0.480 |
Why?
|
| Antidepressive Agents | 2 | 2019 | 2838 | 0.440 |
Why?
|
| Stereotyped Behavior | 2 | 2004 | 136 | 0.440 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2014 | 625 | 0.430 |
Why?
|
| Animals | 51 | 2023 | 168768 | 0.420 |
Why?
|
| Dopamine Agonists | 4 | 2020 | 355 | 0.420 |
Why?
|
| Motor Activity | 4 | 2014 | 2715 | 0.410 |
Why?
|
| Piperidines | 1 | 2019 | 1602 | 0.390 |
Why?
|
| Limbic System | 1 | 2013 | 426 | 0.380 |
Why?
|
| Mood Disorders | 2 | 2017 | 1106 | 0.370 |
Why?
|
| Genes, fos | 4 | 2008 | 183 | 0.360 |
Why?
|
| Models, Psychological | 1 | 2014 | 811 | 0.360 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2022 | 2408 | 0.350 |
Why?
|
| Haloperidol | 5 | 2005 | 397 | 0.350 |
Why?
|
| Stress, Psychological | 5 | 2017 | 4245 | 0.350 |
Why?
|
| Dopamine Antagonists | 5 | 2020 | 296 | 0.340 |
Why?
|
| Desipramine | 1 | 2008 | 184 | 0.330 |
Why?
|
| Dopamine Uptake Inhibitors | 4 | 2014 | 312 | 0.320 |
Why?
|
| Mental Health | 1 | 2022 | 3010 | 0.320 |
Why?
|
| Salvia | 1 | 2008 | 14 | 0.320 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 2126 | 0.320 |
Why?
|
| Microinjections | 3 | 2019 | 327 | 0.300 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2020 | 475 | 0.300 |
Why?
|
| Affect | 1 | 2015 | 1475 | 0.300 |
Why?
|
| Neurotensin | 3 | 2004 | 61 | 0.300 |
Why?
|
| Dizocilpine Maleate | 2 | 2005 | 176 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-fos | 5 | 2013 | 575 | 0.290 |
Why?
|
| Behavioral Research | 1 | 2007 | 54 | 0.290 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2018 | 375 | 0.270 |
Why?
|
| Substance-Related Disorders | 3 | 2020 | 4257 | 0.270 |
Why?
|
| Diltiazem | 1 | 2006 | 133 | 0.260 |
Why?
|
| Phencyclidine | 1 | 2005 | 61 | 0.260 |
Why?
|
| Male | 42 | 2023 | 350115 | 0.250 |
Why?
|
| Reinforcement Schedule | 2 | 2017 | 129 | 0.240 |
Why?
|
| Drug Interactions | 5 | 2011 | 1460 | 0.240 |
Why?
|
| Dopamine Agents | 2 | 2021 | 189 | 0.240 |
Why?
|
| Morphinans | 2 | 2014 | 31 | 0.240 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2006 | 449 | 0.230 |
Why?
|
| Brain | 7 | 2018 | 26388 | 0.230 |
Why?
|
| Estrous Cycle | 1 | 2023 | 73 | 0.230 |
Why?
|
| Depression | 3 | 2015 | 7759 | 0.220 |
Why?
|
| Catalepsy | 2 | 1999 | 34 | 0.220 |
Why?
|
| MicroRNAs | 1 | 2019 | 3751 | 0.220 |
Why?
|
| Rats, Long-Evans | 3 | 2018 | 387 | 0.220 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 692 | 0.210 |
Why?
|
| Receptors, Dopamine | 2 | 2018 | 295 | 0.210 |
Why?
|
| Neostriatum | 1 | 2003 | 250 | 0.210 |
Why?
|
| Glutamates | 1 | 2003 | 398 | 0.210 |
Why?
|
| Electric Stimulation | 6 | 2015 | 1767 | 0.200 |
Why?
|
| Midline Thalamic Nuclei | 1 | 2020 | 13 | 0.200 |
Why?
|
| Stress, Physiological | 1 | 2008 | 1403 | 0.190 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2021 | 70 | 0.190 |
Why?
|
| Sex Factors | 5 | 2021 | 10400 | 0.190 |
Why?
|
| Drug-Seeking Behavior | 1 | 2020 | 48 | 0.190 |
Why?
|
| Neurons | 3 | 2015 | 9340 | 0.190 |
Why?
|
| Dietary Fats | 2 | 2013 | 2016 | 0.180 |
Why?
|
| Choice Behavior | 1 | 2006 | 802 | 0.180 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2008 | 896 | 0.170 |
Why?
|
| Receptors, Purinergic P1 | 1 | 1999 | 109 | 0.170 |
Why?
|
| Methamphetamine | 1 | 2021 | 154 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2021 | 10943 | 0.170 |
Why?
|
| Naltrexone | 2 | 2011 | 307 | 0.170 |
Why?
|
| Castration | 1 | 2018 | 159 | 0.170 |
Why?
|
| Formaldehyde | 1 | 2020 | 353 | 0.160 |
Why?
|
| Opioid Peptides | 1 | 2017 | 42 | 0.150 |
Why?
|
| Psychotropic Drugs | 2 | 2015 | 894 | 0.140 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2009 | 369 | 0.140 |
Why?
|
| Depressive Disorder | 1 | 2009 | 3747 | 0.130 |
Why?
|
| RNA, Messenger | 6 | 2017 | 13035 | 0.130 |
Why?
|
| Cues | 1 | 2020 | 875 | 0.130 |
Why?
|
| Female | 18 | 2023 | 380193 | 0.130 |
Why?
|
| Medial Forebrain Bundle | 2 | 2021 | 45 | 0.130 |
Why?
|
| Dopamine beta-Hydroxylase | 2 | 2005 | 75 | 0.130 |
Why?
|
| Lithium Chloride | 1 | 2015 | 87 | 0.130 |
Why?
|
| Amygdala | 3 | 2008 | 1315 | 0.130 |
Why?
|
| In Situ Hybridization | 3 | 2005 | 1950 | 0.130 |
Why?
|
| Hypothalamus | 1 | 2020 | 1063 | 0.130 |
Why?
|
| Calcium Channels, L-Type | 2 | 2006 | 240 | 0.120 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2018 | 604 | 0.120 |
Why?
|
| Dependovirus | 1 | 2019 | 706 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 1375 | 0.120 |
Why?
|
| Receptors, sigma | 1 | 2014 | 28 | 0.120 |
Why?
|
| Feeding Behavior | 3 | 2020 | 3188 | 0.120 |
Why?
|
| Microglia | 1 | 2022 | 1267 | 0.120 |
Why?
|
| Signal Transduction | 6 | 2020 | 23404 | 0.120 |
Why?
|
| N-Methylaspartate | 1 | 2014 | 231 | 0.110 |
Why?
|
| Neuralgia | 1 | 2020 | 570 | 0.110 |
Why?
|
| Benzeneacetamides | 2 | 2013 | 39 | 0.110 |
Why?
|
| Vaccines, Conjugate | 1 | 2014 | 333 | 0.110 |
Why?
|
| Repressor Proteins | 3 | 2019 | 3024 | 0.110 |
Why?
|
| Receptors, Neurotensin | 2 | 2004 | 18 | 0.110 |
Why?
|
| Receptors, Opioid, mu | 1 | 2013 | 182 | 0.110 |
Why?
|
| Time Factors | 7 | 2015 | 40075 | 0.110 |
Why?
|
| Levodopa | 2 | 2004 | 219 | 0.110 |
Why?
|
| Parvalbumins | 1 | 2014 | 250 | 0.110 |
Why?
|
| Models, Animal | 1 | 2018 | 2173 | 0.100 |
Why?
|
| Tissue Distribution | 1 | 2016 | 2327 | 0.100 |
Why?
|
| Immobility Response, Tonic | 1 | 2011 | 14 | 0.100 |
Why?
|
| Infusions, Intravenous | 1 | 2017 | 2274 | 0.100 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 12073 | 0.100 |
Why?
|
| Drug Administration Routes | 1 | 2011 | 153 | 0.100 |
Why?
|
| Phosphorylation | 3 | 2008 | 8436 | 0.090 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2013 | 422 | 0.090 |
Why?
|
| Swimming | 1 | 2011 | 205 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 2019 | 3424 | 0.090 |
Why?
|
| Interneurons | 1 | 2014 | 577 | 0.080 |
Why?
|
| Receptors, Opioid, delta | 1 | 2008 | 47 | 0.080 |
Why?
|
| Recurrence | 1 | 2020 | 8340 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2003 | 491 | 0.080 |
Why?
|
| Neurogenesis | 1 | 2015 | 838 | 0.080 |
Why?
|
| Neuronal Plasticity | 2 | 2015 | 1423 | 0.080 |
Why?
|
| Learning | 1 | 2017 | 1711 | 0.070 |
Why?
|
| Social Behavior | 1 | 2014 | 1127 | 0.070 |
Why?
|
| Thiazoles | 1 | 2013 | 1483 | 0.070 |
Why?
|
| Insect Hormones | 2 | 1996 | 75 | 0.070 |
Why?
|
| Electrodes, Implanted | 2 | 2008 | 824 | 0.070 |
Why?
|
| Prefrontal Cortex | 2 | 2014 | 2147 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2008 | 19233 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 18034 | 0.060 |
Why?
|
| Pregnancy | 2 | 2022 | 29144 | 0.060 |
Why?
|
| Carbidopa | 1 | 2004 | 31 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6366 | 0.060 |
Why?
|
| Humans | 13 | 2023 | 744366 | 0.060 |
Why?
|
| Reaction Time | 1 | 2011 | 2098 | 0.060 |
Why?
|
| Long-Term Potentiation | 1 | 2006 | 293 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 21833 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 9735 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2008 | 5181 | 0.060 |
Why?
|
| Nicotine | 1 | 2008 | 681 | 0.060 |
Why?
|
| Enzyme Inhibitors | 2 | 2004 | 3799 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2013 | 14561 | 0.060 |
Why?
|
| Gene Expression | 3 | 2005 | 7798 | 0.050 |
Why?
|
| Mice | 8 | 2021 | 81201 | 0.050 |
Why?
|
| Hippocampus | 1 | 2015 | 3675 | 0.050 |
Why?
|
| Dystonia | 1 | 2006 | 363 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 4463 | 0.050 |
Why?
|
| Cell Count | 1 | 2005 | 1856 | 0.050 |
Why?
|
| Heroin | 1 | 2021 | 117 | 0.050 |
Why?
|
| Self-Injurious Behavior | 1 | 2006 | 464 | 0.050 |
Why?
|
| Synaptic Membranes | 2 | 2013 | 91 | 0.050 |
Why?
|
| Receptors, Bombesin | 1 | 1999 | 27 | 0.040 |
Why?
|
| Quinolines | 1 | 2004 | 732 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2017 | 1892 | 0.040 |
Why?
|
| Anesthetics, Local | 1 | 2006 | 985 | 0.040 |
Why?
|
| Autoradiography | 1 | 1999 | 745 | 0.040 |
Why?
|
| Locomotion | 1 | 2021 | 378 | 0.040 |
Why?
|
| Piperazines | 1 | 2008 | 2488 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2009 | 1431 | 0.040 |
Why?
|
| Drosophila Proteins | 2 | 1996 | 1703 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2008 | 377 | 0.030 |
Why?
|
| Hierarchy, Social | 1 | 2014 | 23 | 0.030 |
Why?
|
| Haptens | 1 | 2014 | 166 | 0.030 |
Why?
|
| Alcoholism | 1 | 2005 | 1906 | 0.030 |
Why?
|
| Genes, Insect | 1 | 1995 | 268 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2004 | 1972 | 0.030 |
Why?
|
| Avoidance Learning | 1 | 2015 | 233 | 0.030 |
Why?
|
| Maternal Deprivation | 1 | 2014 | 48 | 0.030 |
Why?
|
| Association Learning | 1 | 2015 | 224 | 0.030 |
Why?
|
| Synaptosomes | 1 | 2013 | 115 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 1999 | 941 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2015 | 599 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2013 | 624 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2013 | 562 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2014 | 1095 | 0.030 |
Why?
|
| Cricetulus | 1 | 2013 | 818 | 0.030 |
Why?
|
| Cytoplasm | 1 | 1996 | 1536 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2014 | 612 | 0.020 |
Why?
|
| CHO Cells | 1 | 2013 | 1409 | 0.020 |
Why?
|
| Immunization | 1 | 2014 | 1256 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 1284 | 0.020 |
Why?
|
| Synaptic Transmission | 2 | 2006 | 1178 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 1425 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 214052 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1996 | 2007 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 1996 | 9647 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 3130 | 0.020 |
Why?
|
| Age Factors | 1 | 2004 | 18373 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2008 | 366 | 0.020 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 2006 | 36 | 0.020 |
Why?
|
| Calcium Channel Agonists | 1 | 2006 | 29 | 0.020 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2006 | 58 | 0.020 |
Why?
|
| Muscimol | 1 | 2006 | 69 | 0.020 |
Why?
|
| Quinoxalines | 1 | 2008 | 290 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 1995 | 1708 | 0.020 |
Why?
|
| GABA Agonists | 1 | 2006 | 111 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2008 | 964 | 0.020 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2006 | 110 | 0.020 |
Why?
|
| Prevalence | 1 | 2021 | 15221 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2006 | 876 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 1997 | 3057 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 6386 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2008 | 1958 | 0.010 |
Why?
|
| Catheterization | 1 | 2008 | 1470 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4561 | 0.010 |
Why?
|
| Body Weight | 1 | 2013 | 4671 | 0.010 |
Why?
|
| Protein Binding | 1 | 2013 | 9384 | 0.010 |
Why?
|
| Syndrome | 1 | 2006 | 3252 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1996 | 1340 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit | 1 | 1997 | 7 | 0.010 |
Why?
|
| Sulpiride | 1 | 1997 | 17 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 9445 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2015 | 4266 | 0.010 |
Why?
|
| Depressive Disorder, Major | 1 | 2015 | 4639 | 0.010 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 1148 | 0.010 |
Why?
|
| Fear | 1 | 2006 | 1440 | 0.010 |
Why?
|
| Seizures | 1 | 2008 | 2859 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1996 | 248 | 0.010 |
Why?
|
| Xenopus | 1 | 1996 | 712 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1997 | 1865 | 0.010 |
Why?
|
| United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 85779 | 0.010 |
Why?
|
| Larva | 1 | 1995 | 519 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1996 | 895 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 1997 | 7721 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1996 | 751 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1996 | 1547 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1995 | 1202 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1997 | 1783 | 0.010 |
Why?
|
| Obesity | 1 | 2013 | 12746 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 2839 | 0.010 |
Why?
|
| Point Mutation | 1 | 1995 | 1624 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 4320 | 0.010 |
Why?
|
| Drosophila | 1 | 1996 | 1491 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 6171 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1995 | 4740 | 0.000 |
Why?
|
| Transcription Factors | 2 | 1996 | 12207 | 0.000 |
Why?
|
| Base Sequence | 1 | 1995 | 12797 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 13814 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 18111 | 0.000 |
Why?
|
| Phenotype | 1 | 1995 | 16367 | 0.000 |
Why?
|